Experience the revolutionary Essilor me-check Ophthalmic Screening Solution, a comprehensive tool that assesses Meibomian gland dysfunction, the primary cause of Dry Eye. This cutting-edge solution combines advanced imaging technologies and complex algorithms to deliver effortless and accurate screening for this condition. Unlock the power of the Essilor me-check Ophthalmic Screening Solution to effortlessly evaluate Meibomian gland dysfunction and provide targeted treatment for patients. With its advanced imaging technologies, comprehensive evaluation tools, and user-friendly interface, me-check simplifies the screening process, enabling timely interventions and improved patient outcomes.
- 3D and Infrared Imaging: Captures detailed images of Meibomian glands, providing comprehensive visualization for evaluation.
- Automatic Focus Detection: Streamlines the screening process and ensures efficiency during image capture.
- Accurate and Reliable Results: The solution is designed to deliver precise and consistent screening outcomes for evaluating Meibomian gland dysfunction.
- Espansione Ecosystem: Part of a complete portfolio of ophthalmic care solutions that prioritize safety, reliability, and usability.
- Collaboration with Experts: Developed in partnership with renowned experts in the field, including Dr. Heiko Pult and Prof. James Wolffsohn.
- Meiboscale and OSDI-6 Integration: Incorporates Dr. Pult's Meiboscale and Prof. Wolffsohn's OSDI-6 test for enhanced screening accuracy.
- Complex Mathematical Algorithms: Utilizes advanced mathematical algorithms to ensure accurate analysis and evaluation.
- Intuitive User Interface: Operator-friendly interface designed for ease of use and seamless workflow.
- Comprehensive Meibomian Gland Evaluation: Utilizes 3D imaging and infrared imaging to capture detailed gland images, enabling thorough assessment.
- Efficient Screening Process: Quick and non-invasive eye test completed within 5 minutes, enhancing patient comfort and convenience.
- Collaborative Expertise: Developed in collaboration with leading experts, incorporating their validated assessment tools and knowledge.
- Targeted Treatment: Provides a comprehensive overview of the patient's condition, guiding practitioners in diagnosing and addressing the root causes of inflammatory conditions.
- Repeatable and Reliable Screening: Ensures consistent and accurate screening results for Meibomian gland dysfunction.
- Streamlined Workflow: User-friendly interface and automated processes optimize efficiency and productivity in ophthalmic care.
- Imaging Technologies: 3D imaging, Infrared imaging
- Screening Time: Typically completed within 5 minutes
- Integration: Meiboscale and OSDI-6 test integration for comprehensive evaluation
- Software: Built using complex mathematical algorithms for accurate screening analysis
- User Interface: Intuitive and operator-friendly interface for ease of use